Suppr超能文献

一氧化氮在体内刺激大鼠空肠肠液吸收中的意义。

Significance of nitric oxide in the stimulation of intestinal fluid absorption in the rat jejunum in vivo.

作者信息

Schirgi-Degen A, Beubler E

机构信息

Department of Experimental and Clinical Pharmacology, Karl-Franzens-University of Graz, Austria.

出版信息

Br J Pharmacol. 1995 Jan;114(1):13-8. doi: 10.1111/j.1476-5381.1995.tb14899.x.

Abstract
  1. The effects of inhibiting nitric oxide (NO)-synthase on fluid transport, mucosal cyclic GMP and cyclic AMP levels and intraluminal prostaglandin E2 (PGE2)-release were studied in a model of ligated jejunal loops of anaesthetized rats in vivo. Experiments were performed under basal conditions as well as under conditions, when net fluid secretion was induced by Escherichia coli heat stable enterotoxin a (E. coli STa) or PGE2. 2. Intravenous infusion of the NO-synthase inhibitor N omega-nitro-L-arginine methyl ester (L-NAME, 0.25-50 mg kg-1, 45 min) dose-dependently reversed net fluid absorption to net secretion, whereas infusion of D-NAME, the inactive enantiomer of L-NAME, in corresponding doses did not influence net fluid transport. N omega-nitro-L-arginine (L-NOARG, 25 mg kg-1), another NO-synthase inhibitor, also elicited net secretion of fluid. 3. L-NAME (25 mg kg-1)-induced net fluid secretion was reversed to net absorption by infusion of L-arginine (400 mg kg-1) or sodium nitroprusside (1 mg kg-1) and s.c. administration of indomethacin (10 mg kg-1). Hexamethonium (1 mg kg-1, s.c.), a ganglionic blocker and granisetron (100 micrograms kg-1, s.c.), a 5-HT3-receptor antagonist, did not influence L-NAME-induced net secretion. 4. Net fluid secretion induced by intraluminal instillation of E. coli STa (10 units ml-1) was enhanced by infusion of L-NAME (25 mg kg-1) and was inhibited by infusion of L-arginine (400 mg kg-1) and sodium nitroprusside (1 mg kg-1). D-Arginine (400 mg kg-1) did not influence E. coli STa-induced fluid secretion. Likewise, net fluid secretion induced by i.a. infusion of PGE2 (79 ng ml-1, 30 min) was enhanced by infusion of L-NAME and was inhibited by L-arginine and sodium nitroprusside. D-Arginine(400 mg kg-1) did not influence PGE2-induced fluid secretion.5. PGE2 levels in intraluminal fluid were not elevated after infusion of L-NAME (25mgkg-1) compared to controls.6. Mucosal cyclic GMP and cyclic AMP levels after L-NAME-treatment were not different from control values.7. These results indicate that nitric oxide plays an important role in the regulation of intestinal fluid transport. The data suggest a nitric oxide-dependent proabsorptive tone in the intestine, which possibly involves the enteric nervous system and suppression of prostaglandin formation. This proabsorptive tone also may downregulate fluid secretion induced by E. coli STa or PGE2.
摘要
  1. 在麻醉大鼠体内结扎空肠袢模型中,研究了抑制一氧化氮(NO)合酶对液体转运、黏膜环鸟苷酸(cGMP)和环腺苷酸(cAMP)水平以及肠腔内前列腺素E2(PGE2)释放的影响。实验在基础条件下以及由大肠杆菌热稳定肠毒素a(E. coli STa)或PGE2诱导净液体分泌的条件下进行。2. 静脉输注NO合酶抑制剂Nω-硝基-L-精氨酸甲酯(L-NAME,0.25 - 50 mg kg-1,45分钟)剂量依赖性地使净液体吸收转变为净分泌,而输注相应剂量的L-NAME无活性对映体D-NAME则不影响净液体转运。另一种NO合酶抑制剂Nω-硝基-L-精氨酸(L-NOARG,25 mg kg-1)也引起液体净分泌。3. 输注L-精氨酸(400 mg kg-1)或硝普钠(1 mg kg-1)以及皮下注射吲哚美辛(10 mg kg-1)可使L-NAME(25 mg kg-1)诱导的液体净分泌转变为净吸收。神经节阻滞剂六甲铵(1 mg kg-1,皮下注射)和5-HT3受体拮抗剂格拉司琼(100 μg kg-1,皮下注射)不影响L-NAME诱导的净分泌。4. 肠腔内滴注E. coli STa(10单位ml-1)诱导的液体净分泌因输注L-NAME(25 mg kg-1)而增强,因输注L-精氨酸(400 mg kg-1)和硝普钠(1 mg kg-1)而受到抑制。D-精氨酸(400 mg kg-1)不影响E. coli STa诱导的液体分泌。同样,腹腔内输注PGE2(79 ng ml-1,30分钟)诱导的液体净分泌因输注L-NAME而增强,因L-精氨酸和硝普钠而受到抑制。D-精氨酸(400 mg kg-1)不影响PGE2诱导的液体分泌。5. 与对照组相比,输注L-NAME(25 mg kg-1)后肠腔内液体中的PGE2水平未升高。6. L-NAME处理后的黏膜cGMP和cAMP水平与对照值无差异。7. 这些结果表明,一氧化氮在肠道液体转运调节中起重要作用。数据提示肠道中存在一氧化氮依赖性的促吸收张力,这可能涉及肠神经系统并抑制前列腺素形成。这种促吸收张力也可能下调由E. coli STa或PGE2诱导的液体分泌。
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25d7/1510187/33df1e616624/brjpharm00161-0023-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验